Skip Navigation LinksHome > September/October 2007 - Volume 14 - Issue 5 > Reliéva, a Mahonia Aquifolium Extract for the Treatment of A...
American Journal of Therapeutics:
doi: 10.1097/MJT.0b013e31814002c1
Original Article

Reliéva, a Mahonia Aquifolium Extract for the Treatment of Adult Patients With Atopic Dermatitis

Donsky, Howard MD1*; Clarke, Don MD2

Collapse Box

Abstract

This clinical study was conducted to determine the efficacy and safety of Reliéva cream in adult patients with atopic dermatitis (eczema). This was an open-label trial in 42 patients with atopic dermatitis treated for 12 weeks with Reliéva cream (a homeopathic product containing Psorberine, a proprietary Mahonia aquifolium extract). Efficacy and safety was assessed using Eczema Area and Severity Index scores and a Subject Reported Evaluation of Treatment. The results showed significant (P < 0.05) improvements with respect to Eczema Area and Severity Index scores by comparison to subjects' baseline scores. In addition, subjects responding to a posttreatment evaluation questionnaire indicated a substantial benefit when rating effectiveness, itching, and appearance as a result of using the study preparation. Reliéva cream appears to be a safe and effective treatment for adult patients with atopic dermatitis (eczema).

© 2007 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.